Recent cancer incidence trends in an observational clinical cohort of HIV-infected patients in the US, 2000 to 2011

[21] Engels EA(2012)Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma Cancer 118 3977-833

[22] Biggar RJ(2011)Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial Cancer Chemother Pharmacol 68 827-402

[23] Hall HI(2012)Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Anitviral Society-USA Panel JAMA 308 387-881

[24] Cross H(2010)Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001–2007 AIDS Res Hum Retroviruses 26 875-38

[25] Crutchfield A(2006)The epidemiology of HIV/AIDS in women in the southern United States Sex Transm Dis 33 S32-1826

[26] Finch JL(2011)Estimated HIV incidence in the United States, 2006–2009 PLoS One 6 e17502-1363

[27] Jemal A(2009)Effect of early versus deferred antiretroviral therapy for HIV on survival N Engl J Med 360 1815-undefined

[28] Bray F(2009)Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Lancet 373 1352-undefined

[29] Center MM(undefined)undefined undefined undefined undefined-undefined

[30] Ferlay J(undefined)undefined undefined undefined undefined-undefined

[21] Engels EA(2012)Pooled analysis of AIDS malignancy consortium trials evaluating rituximab plus CHOP or infusional EPOCH chemotherapy in HIV-associated non-Hodgkin lymphoma Cancer 118 3977-833

[22] Biggar RJ(2011)Pilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) trial Cancer Chemother Pharmacol 68 827-402

[23] Hall HI(2012)Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Anitviral Society-USA Panel JAMA 308 387-881

[24] Cross H(2010)Enrollment, retention, and visit attendance in the University of North Carolina Center for AIDS Research HIV clinical cohort, 2001–2007 AIDS Res Hum Retroviruses 26 875-38

[25] Crutchfield A(2006)The epidemiology of HIV/AIDS in women in the southern United States Sex Transm Dis 33 S32-1826

[26] Finch JL(2011)Estimated HIV incidence in the United States, 2006–2009 PLoS One 6 e17502-1363

[27] Jemal A(2009)Effect of early versus deferred antiretroviral therapy for HIV on survival N Engl J Med 360 1815-undefined

[28] Bray F(2009)Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies Lancet 373 1352-undefined

[29] Center MM(undefined)undefined undefined undefined undefined-undefined

[30] Ferlay J(undefined)undefined undefined undefined undefined-undefined